Lipids and Lipid Derivatives
Medchemexpress LLC Triolein (standard) | 122-32-7 | 885.43 | 25 MG
Triolein (Standard) is the analytical standard of Triolein intended for research and analytical applications. It is a symmetric triacylglycerol that reduces upregulation of MMP-1 and has strong antioxidant and anti-inflammatory activities. This compound is commonly used in qualitative, quantitative, and methodological research experiments in HPLC, GC, and MS, serving as a reference standard supplied for assay.
- Analytical standard for research
- Symmetric triacylglycerol
- Reduces upregulation of MMP-1
- Strong antioxidant and anti-inflammatory activities
- Suitable for HPLC research experiments
- Suitable for GC research experiments
- Suitable for MS research experiments
Selleck Chemical LLC uridine triacetate
Uridine triacetate (Vistonuridine PN401) is an orally active prodrug of the naturally occurring nucleoside uridine It is used for the treatment of hereditary orotic aciduria (Xuriden) or for the emergency treatment of fluorouracil or capecitabine overdose or toxicity
Cambridge Isotope Laboratories Trioctanoin (1 1 1-13C3 99%) 0 5 g
Trioctanoin (1 1 1-13C3 99%) 0 5 g
Medchemexpress LLC Glyceryl 1-monooctanoate | 502-54-5 | 99.0% | 218.29 | 10 MG
Glyceryl 1-monooctanoate is a glycerol monolaurate derivative and a broad-spectrum antimicrobial. It suppresses the growth of pathogenic yeast (Candida albicans and Candida parapsilosis), as well as Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli, Klebsiella pneumoniae) bacteria.
- Antifungal activity against saprophytic fungi including Aspergillus niger, Penicillium roqueforti, Penicillium jensenii, Alternaria sp., Phoma sp.
- Antifungal activity against pathogenic fungi including Trichophyton mentagrophytes and Trichophyton rubrum.
- Antifungal activity against pathogenic yeast with a minimum inhibitory concentration (MIC) of 200 mg/L for Candida albicans.
- Antifungal activity against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli, Klebsiella pneumoniae) bacteria.
Medchemexpress LLC Trilaurin | 538-24-9 | >99.7% | 100 MG
Trilaurin is an endogenous metabolite that could inhibit the formation of neoplasms initiated by dimethylbenzanthracene (DMBA) and promoted by croton oil. It appears as a white to off-white solid and is classified as a lipid.
- Endogenous metabolite
- Inhibits neoplasm formation initiated by DMBA
- Inhibits neoplasm formation promoted by croton oil
- Appears as a white to off-white solid
- Molecular weight of 639.00
- Chemical formula is C39H74O6
- Classified as a lipid
Apexbio Technology LLC Triolein 122-32-7 1g
Triolein (CAS 122-32-7) is a neutral triglyceride composed of glycerol esterified with three oleic acid molecules It is utilized in biomedical research for its involvement in lipid metabolism and transport processes Studies have explored Triolein also known as glyceryl trioleate for its potential to modulate very-long-chain fatty acid (VLCFA) metabolism Notably it has been investigated as a dietary intervention in X-linked adrenoleukodystrophy aiming to alter the accumulation of VLCFAs implicated in disease pathology As such Triolein serves as a model compound for understanding lipid-based therapeutic strategies in metabolic and neurodegenerative disorders
Apexbio Technology LLC TRIACETIN-500MG
Triacetin (CAS No 102-76-1) is a versatile compound often used in biomedical research due to its origin as a triglyceride formed from glycerol and acetic acid Known for its role as an excipient it is explored within pharmacological studies for its ability to modulate pathways related to drug delivery and stability Triacetin exhibits in vitro activity typically in the nanomolar to low micromolar range making it relevant for experiments involving solvent-enhanced drug solubility It is commonly applied in cell models and animal studies to investigate its efficacy as a plasticizer and a potential drug carrier Researchers utilize triacetin in drug screening processes particularly focusing on its effects in enhancing the bioavailability of active pharmaceutical ingredients Experimental concentrations typically depend on the specific research design ensuring flexibility and specificity in its application across various experimental setups